Krystal Biotech (KRYS) EBITDA (2016 - 2026)
Krystal Biotech's EBITDA came in at $72.65 million for Q3 2026, up 69.8% from $42.77 million a year earlier and up 21.4% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) EBITDA (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Krystal Biotech reported EBITDA of $233.47 million, up 42.4% year-over-year; for FY2025, it came in at $167.02 million, up 132.8% from FY2024.
- Going back by year, EBITDA was $71.75 million in FY2024, -$105.89 million in FY2023, -$139.73 million in FY2022 and -$64.59 million in FY2021.
- The Q3 2026 figure represents the highest quarterly EBITDA in data going back to Q3 2016.
- Year-over-year, EBITDA has increased for six consecutive quarters, with growth averaging 191.8% over the last seven quarters.
- Business Quant data shows KRYS's EBITDA at $59.82 million (Q2 2026), $55.21 million (Q1 2026) and $45.79 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 72.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 72.65 Mn |
| Jun 30, 2026 | 59.82 Mn |
| Mar 31, 2026 | 55.21 Mn |
| Dec 31, 2025 | 45.79 Mn |
| Sep 30, 2025 | 42.77 Mn |
| Jun 30, 2025 | 40.70 Mn |
| Mar 31, 2025 | 37.66 Mn |
| Dec 31, 2024 | 42.77 Mn |
| Sep 30, 2024 | 23.77 Mn |
| Jun 30, 2024 | 10.37 Mn |
| Mar 31, 2024 | -5.26 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | -25.17 Mn |
| Jun 30, 2023 | -37.01 Mn |
| Mar 31, 2023 | -48.12 Mn |
| Dec 31, 2022 | -33.68 Mn |
| Sep 30, 2022 | -30.48 Mn |
| Jun 30, 2022 | -27.78 Mn |
| Mar 31, 2022 | -49.21 Mn |
| Dec 31, 2021 | -21.09 Mn |
API Access
Krystal Biotech EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();